Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Active Support for Hospitalised COVID-19 Patients
PACTR202006473370201Phase 3Not yet recruiting
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Apr 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label trial of aspirin, losartan and simvastatin in coronavirus disease 2019 (COVID-19) (8 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: In-hospital death. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
aspirinlosartansimvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202006473370201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006473370201.